No Data
Express News | Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Akebia Therapeutics Inc - Vafseo Expected to Be Available in U.S. in January 2025
Express News | U.S. Renal Care Enrolled First Patients in the Voice Collaborative Clinical Trial of Vafseo® (Vadadustat) for Ckd Patients on Dialysis
U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo (Vadadustat) for CKD Patients on Dialysis
Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
Cuhai88 : Shook for a long time.
小竜 OP : I can wait
Cuhai88 : The trend is still shaking.
小竜 OP : Nothing is smooth sailing. be confidence.
101674396 : Why drop to below $1.9? Due to Earning result .